ADARB1 and glioblastoma: ADAR2 editing of miR222/221 and miR-21 precursors, for example, reduces expression of mature onco-miRNAs in vitro and in vivo, resulting in impaired cell proliferation and metastasis of GBM (Tomaselli et al., 2015).